Omega-3 and 6 Linked to Lower Cancer Hazard

Summary: Higher amounts of omega-3 and omega-6 fatty acids are linked with a lower risk of several types of cancers, including head, colon, stomach, and lung cancers, according to a study of over 250, 000 members. The results highlight the potential of these “healthy fat” in cancer prevention, irrespective of BMI or attitude.

The study also suggests that omega-6 benefits are especially powerful for younger people, especially girls. Benefits lead to eating adjustments that may help lower cancer risk.

Major Information

  • Higher omega-3 rates correlate with lower levels of stomach, chest, and lung cancers.
  • Omega-6 was associated with reduced chance for 14 cancers, including cancer and brain cancers.
  • Benefits remained constant regardless of factors like BMI, drinking usage, or physical action.

Origin: University of Georgia

In addition to lowering your lipid, keeping your brain healthy and improving mental heath, &nbsp, fresh research&nbsp, from the University of Georgia suggests omega-3 and omega-6 fatty acid may help ward off a variety of cancers.

Higher rates of omega-3 and omega-6 fatty acid were linked to a lower risk of developing cancers, according to the study, which relied on information from more than 250 000 people.

” Higher omega-3 and omega-6 levels were associated with lower rates of cancer”, said&nbsp, Yuchen Zhang, lead author of the study and a doctoral student in UGA ‘s&nbsp, College of Public Health.

These studies suggest that the typical person should increase the intake of these fatty acid in their diets.

High omega-6 rates led to lower levels of 14 various cancers, including head, malignant melanoma, urine and more. Credit: Neuroscience News

Individuals who had higher omega-3 levels had lower levels of intestines, stomach, and lung cancer as well as lower levels of additional digestive tract tumors.

High omega-6 rates led to lower levels of 14 various cancers, including head, malignant melanoma, urine and more.

Healthy fat lower the risk of contracting 19 different cancers

The research incorporated information from a study conducted in the United Kingdom and involved more than 250, 000 individuals who had been followed for more than a decade. Of those respondents, about 30, 000 developed some form of malignancy during the research time.

Some earlier studies established links between fatty acid levels and risk of developing cancer. But, no studies may clearly identify whether omega-3 and omega-6 fatty acid reduced cancer costs or increased the likelihood of surviving a cancer treatment.

Interestingly, other risk factors, such as BMI, alcohol consumption, or physical activity, did not affect the advantages of high fatty acid levels.

Fish oil supplements have a variety of heath advantages.

Known as “healthy fat”, omega-3 and omega-6 fats acids are vital for human health. They can be found in oily fish, beans, and even some plant oils, like canola oil.

However, the majority of Americans are probably not consuming enough of these products to meet the recommended intake.

That’s why some people turn to fish oil supplements. One of the most well-known nutritional supplements available today is made with them, and for good reason.

Past studies&nbsp, suggest omega-3 pills can reduce the risk of developing higher cholesterol and lower the risk of heart disease.

Advantages of fish oil may not be one-size-fits-all

But the decision to take the popular fish oil pills is n’t &nbsp, one-size-fits-all.

In the present study, for example, the scientists found that higher omega-3 rates may be associated with a somewhat higher risk of prostate cancer.

” For women, it’s an easy decision: Eat more omega-3″, said&nbsp, Kaixiong Ye, corresponding author of the study and an associate professor in UGA ‘s&nbsp, Franklin College of Arts and Sciences.

The experts also saw a stronger beneficial impact of omega-6 in younger members, especially women.

Published in the International Journal of Cancer, &nbsp, the investigation &nbsp, was co-authored by Yitang Sun, a graduate student of UGA’s biology system, and&nbsp, Suhang Song&nbsp, and&nbsp, Ye Shen, of UGA’s College of Public Health. Nikhil Khankari and Thomas Brenna are further co-authors.

About this information from brain cancer study

Author: Savannah Peat
Source: University of Georgia
Contact: Savannah Peat – University of Georgia
Image: The image is credited to Neuroscience News

Original Research: Start exposure.
” Associations of blood omega-6 and omega-3 fatty acid with general and 19 site-specific tumors: A population-based cohort study in UK Biobank” by Yuchen Zhang et al. International Journal of Cancer


Abstract

Associations of blood omega-6 and omega-3 fatty acid with general and 19 site-specific tumors: A population-based demographic study in UK Biobank

Previous studies on the link between polyunsaturated fatty acids ( PUFAs ) and cancer incidence were inconsistent.

We investigated the associations of blood omega-3 and omega-6 PUFAs with the occurrence of general and 19 site-specific malignancies in a large potential group. 253, 138 qualified UK Biobank members were included in our research. With a indicate follow-up of 12.9 times, 29, 838 individuals were diagnosed with cancer.

The plasma levels of omega-3 and omega-6 PUFAs were expressed as percentages of total fatty acids ( omega-3 % and omega-6 % ). In our principal models, both omega-6 % and omega-3 % were directly associated with general cancer incidence ( HR per SD = 0.98, 95 % CI = 0.96–0.99, HR per SD = 0.99, 95 % CI = 0.97–1.00, both ).

Of the 19 site-specific cancers available, 14 were associated with omega-6 % and five with omega-3 %, all indicating inverse associations, with the exception that prostate cancer was positively associated with omega-3 % ( HR per SD = 1.03, 95 % CI = 1.01–1.05 ).

Our population-based group investigation in UK Biobank indicates smaller opposite associations of blood omega-6 and omega-3 PUFAs with the severity of general and most site-specific cancers, although there are significant exceptions, such as prostate cancers.

[ihc-register]